Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous system.

Küsters-Vandevelde HV, Klaasen A, Küsters B, Groenen PJ, van Engen-van Grunsven IA, van Dijk MR, Reifenberger G, Wesseling P, Blokx WA.

Acta Neuropathol. 2010 Mar;119(3):317-23. doi: 10.1007/s00401-009-0611-3.

2.

GNA11 and N-RAS mutations: alternatives for MAPK pathway activating GNAQ mutations in primary melanocytic tumours of the central nervous system.

Gessi M, Hammes J, Lauriola L, Dörner E, Kirfel J, Kristiansen G, zur Muehlen A, Denkhaus D, Waha A, Pietsch T.

Neuropathol Appl Neurobiol. 2013 Jun;39(4):417-25. doi: 10.1111/j.1365-2990.2012.01288.x.

PMID:
22758774
3.

Mutations in g protein encoding genes and chromosomal alterations in primary leptomeningeal melanocytic neoplasms.

Küsters-Vandevelde HV, van Engen-van Grunsven IA, Coupland SE, Lake SL, Rijntjes J, Pfundt R, Küsters B, Wesseling P, Blokx WA, Groenen PJ.

Pathol Oncol Res. 2015 Apr;21(2):439-47. doi: 10.1007/s12253-014-9841-3.

PMID:
25315378
4.

Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system.

van de Nes J, Gessi M, Sucker A, Möller I, Stiller M, Horn S, Scholz SL, Pischler C, Stadtler N, Schilling B, Zimmer L, Hillen U, Scolyer RA, Buckland ME, Lauriola L, Pietsch T, Waha A, Schadendorf D, Murali R, Griewank KG.

J Neurooncol. 2016 May;127(3):435-44. doi: 10.1007/s11060-015-2052-2.

PMID:
26744134
5.

Oncogenic mutations in melanomas and benign melanocytic nevi of the female genital tract.

Tseng D, Kim J, Warrick A, Nelson D, Pukay M, Beadling C, Heinrich M, Selim MA, Corless CL, Nelson K.

J Am Acad Dermatol. 2014 Aug;71(2):229-36. doi: 10.1016/j.jaad.2014.03.033.

6.

Immunohistochemical and molecular pathology of ocular uveal melanocytoma: evidence for somatic GNAQ mutations.

Mudhar HS, Doherty R, Salawu A, Sisley K, Rennie IG.

Br J Ophthalmol. 2013 Jul;97(7):924-8. doi: 10.1136/bjophthalmol-2013-303291.

PMID:
23685997
7.

BRAF and GNAQ mutations in melanocytic tumors of the oral cavity.

Cohen Y, Goldenberg-Cohen N, Akrish S, Shani T, Amariglio N, Dratviman-Storobinsky O, Kaplan I, Barshack I, Hirshberg A.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Dec;114(6):778-84. doi: 10.1016/j.oooo.2012.09.001.

PMID:
23159116
8.

Melanocytomas of the central nervous system: a clinicopathological and molecular study.

Wang H, Zhang S, Wu C, Zhang Z, Qin T.

Eur J Clin Invest. 2013 Aug;43(8):809-15. doi: 10.1111/eci.12109.

PMID:
23683178
9.

Primary melanocytic tumors of the central nervous system: a review with focus on molecular aspects.

Küsters-Vandevelde HV, Küsters B, van Engen-van Grunsven AC, Groenen PJ, Wesseling P, Blokx WA.

Brain Pathol. 2015 Mar;25(2):209-26. doi: 10.1111/bpa.12241. Review.

PMID:
25534128
10.

Is it a primary or metastatic melanocytic neoplasm of the central nervous system?: A molecular based approach.

Cornejo KM, Hutchinson L, Cosar EF, Smith T, Tomaszewicz K, Dresser K, Deng A.

Pathol Int. 2013 Nov;63(11):559-64. doi: 10.1111/pin.12107.

PMID:
24274719
11.

Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi.

Van Raamsdonk CD, Bezrookove V, Green G, Bauer J, Gaugler L, O'Brien JM, Simpson EM, Barsh GS, Bastian BC.

Nature. 2009 Jan 29;457(7229):599-602. doi: 10.1038/nature07586.

12.

Mutation scanning of BRAF, NRAS, KIT, and GNAQ/GNA11 in oral mucosal melanoma: a study of 57 cases.

Lyu J, Wu Y, Li C, Wang R, Song H, Ren G, Guo W.

J Oral Pathol Med. 2016 Apr;45(4):295-301. doi: 10.1111/jop.12358.

PMID:
26399561
13.

Oncogenic GNAQ and GNA11 mutations in uveal melanoma in Chinese.

Xu X, Wei WB, Li B, Gao F, Zhang Z, Jonas JB.

PLoS One. 2014 Oct 3;9(10):e109699. doi: 10.1371/journal.pone.0109699.

14.

Mutations in GNA11 in uveal melanoma.

Van Raamsdonk CD, Griewank KG, Crosby MB, Garrido MC, Vemula S, Wiesner T, Obenauf AC, Wackernagel W, Green G, Bouvier N, Sozen MM, Baimukanova G, Roy R, Heguy A, Dolgalev I, Khanin R, Busam K, Speicher MR, O'Brien J, Bastian BC.

N Engl J Med. 2010 Dec 2;363(23):2191-9. doi: 10.1056/NEJMoa1000584.

15.

Lack of oncogenic GNAQ mutations in melanocytic lesions of the conjunctiva as compared to uveal melanoma.

Dratviman-Storobinsky O, Cohen Y, Frenkel S, Pe'er J, Goldenberg-Cohen N.

Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6180-2. doi: 10.1167/iovs.10-5677.

PMID:
20631239
16.

Low mutational burden of eight genes involved in the MAPK/ERK, PI3K/AKT, and GNAQ/11 pathways in female genital tract primary melanomas.

Pappa KI, Vlachos GD, Roubelakis M, Vlachos DE, Kalafati TG, Loutradis D, Anagnou NP.

Biomed Res Int. 2015;2015:303791. doi: 10.1155/2015/303791.

17.

Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.

Reifenberger J, Knobbe CB, Sterzinger AA, Blaschke B, Schulte KW, Ruzicka T, Reifenberger G.

Int J Cancer. 2004 Apr 10;109(3):377-84.

18.

SF3B1 and EIF1AX mutations occur in primary leptomeningeal melanocytic neoplasms; yet another similarity to uveal melanomas.

Küsters-Vandevelde HV, Creytens D, van Engen-van Grunsven AC, Jeunink M, Winnepenninckx V, Groenen PJ, Küsters B, Wesseling P, Blokx WA, Prinsen CF.

Acta Neuropathol Commun. 2016 Jan 15;4:5. doi: 10.1186/s40478-016-0272-0.

19.

Improved discrimination of melanotic schwannoma from melanocytic lesions by combined morphological and GNAQ mutational analysis.

Küsters-Vandevelde HV, van Engen-van Grunsven IA, Küsters B, van Dijk MR, Groenen PJ, Wesseling P, Blokx WA.

Acta Neuropathol. 2010 Dec;120(6):755-64. doi: 10.1007/s00401-010-0749-z. Review.

20.

Identification of unique MEK-dependent genes in GNAQ mutant uveal melanoma involved in cell growth, tumor cell invasion, and MEK resistance.

Ambrosini G, Pratilas CA, Qin LX, Tadi M, Surriga O, Carvajal RD, Schwartz GK.

Clin Cancer Res. 2012 Jul 1;18(13):3552-61. doi: 10.1158/1078-0432.CCR-11-3086.

Items per page

Supplemental Content

Support Center